Home › Calculator › ZTS Dividend Calculator 2026
ZTS DRIP Calculator & Dividend Yield 2026
2.67% YieldHealthcareZoetis Inc. · NYSE
Price: $78.23 · Annual div: $2.09/share · Frequency: quarterly · Payout ratio: 35% · Ex-div: 2026-10-30
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ZTS pays your bills
Year your monthly dividend income covers each expense (based on current settings)
ZTS Dividend History — Last 55 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-10-30Latest | 2026-12-01 | $0.5300 | 3.79% | $69.10 |
| 2026-07-20 | 2026-09-01 | $0.5300 | 2.88% | $72.45 |
| 2026-04-20 | 2026-06-02 | $0.5300 | 2.18% | $117.29 |
| 2026-01-20 | 2026-03-03 | $0.5300 | 2.01% | $125.92 |
| 2025-10-31 | 2025-12-02 | $0.5000 | 1.36% | $146.95 |
| 2025-07-18 | 2025-09-03 | $0.5000 | 1.21% | $159.19 |
| 2025-04-21 | 2025-06-03 | $0.5000 | 1.15% | $161.91 |
| 2025-01-21 | 2025-03-04 | $0.5000 | 1.10% | $162.61 |
| 2024-10-31 | 2024-12-03 | $0.4320 | 0.89% | $194.42 |
| 2024-07-18 | 2024-09-04 | $0.4320 | 1.19% | $172.58 |
| 2024-04-18 | 2024-06-04 | $0.4320 | 1.19% | $167.02 |
| 2024-01-18 | 2024-03-01 | $0.4320 | 0.98% | $196.57 |
| 2023-10-31 | 2023-12-01 | $0.3750 | 0.87% | $172.73 |
| 2023-07-20 | 2023-09-01 | $0.3750 | 0.85% | $170.23 |
| 2023-04-20 | 2023-06-01 | $0.3750 | 0.84% | $167.66 |
| 2023-01-19 | 2023-03-01 | $0.3750 | 0.92% | $146.85 |
| 2022-10-31 | 2022-12-01 | $0.3250 | 0.86% | $151.35 |
| 2022-07-20 | 2022-09-01 | $0.3250 | 0.70% | $174.21 |
| 2022-04-20 | 2022-06-01 | $0.3250 | 0.60% | $191.11 |
| 2022-01-19 | 2022-03-01 | $0.3250 | 0.46% | $234.03 |
| 2021-10-28 | 2021-12-01 | $0.2500 | 0.51% | $196.19 |
| 2021-07-20 | 2021-09-01 | $0.2500 | 0.50% | $189.29 |
| 2021-04-20 | 2021-06-01 | $0.2500 | 0.57% | $157.89 |
| 2021-01-19 | 2021-03-01 | $0.2500 | 0.52% | $163.59 |
| 2020-10-20 | 2020-12-01 | $0.2000 | — | — |
| 2020-07-16 | 2020-09-01 | $0.2000 | — | — |
| 2020-04-16 | 2020-06-01 | $0.2000 | — | — |
| 2020-01-16 | 2020-03-03 | $0.2000 | — | — |
| 2019-10-21 | 2019-12-02 | $0.1640 | — | — |
| 2019-07-18 | 2019-09-03 | $0.1640 | — | — |
| 2019-04-17 | 2019-06-03 | $0.1640 | — | — |
| 2019-01-17 | 2019-03-01 | $0.1640 | — | — |
| 2018-11-19 | 2018-12-03 | $0.1260 | — | — |
| 2018-07-19 | 2018-09-04 | $0.1260 | — | — |
| 2018-04-19 | 2018-06-01 | $0.1260 | — | — |
| 2018-01-18 | 2018-03-01 | $0.1260 | — | — |
| 2017-11-08 | 2017-12-01 | $0.1050 | — | — |
| 2017-06-13 | 2017-09-01 | $0.1050 | — | — |
| 2017-04-04 | 2017-06-01 | $0.1050 | — | — |
| 2017-01-18 | 2017-03-01 | $0.1050 | — | — |
| 2016-11-01 | 2016-12-01 | $0.0950 | — | — |
| 2016-06-28 | 2016-08-30 | $0.0950 | — | — |
| 2016-04-05 | 2016-06-01 | $0.0950 | — | — |
| 2016-01-19 | 2016-03-01 | $0.0950 | — | — |
| 2015-11-03 | 2015-12-01 | $0.0830 | — | — |
| 2015-08-11 | 2015-09-01 | $0.0830 | — | — |
| 2015-04-07 | 2015-06-02 | $0.0830 | — | — |
| 2015-01-20 | 2015-03-03 | $0.0830 | — | — |
| 2014-11-03 | 2014-12-02 | $0.0720 | — | — |
| 2014-08-18 | 2014-09-02 | $0.0720 | — | — |
| 2014-04-24 | 2014-06-02 | $0.0720 | — | — |
| 2014-01-28 | 2014-03-04 | $0.0720 | — | — |
| 2013-10-30 | 2013-12-02 | $0.0650 | — | — |
| 2013-07-30 | 2013-09-02 | $0.0650 | — | — |
| 2013-04-29 | 2013-06-06 | $0.0650 | — | — |
About Zoetis Inc. (ZTS) — Dividend Analysis 2026
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Similar dividend stocks to ZTS
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ZTS DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ZTS position with:
🌍 ZTS Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ZTS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.67% | -0.13% | $267 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.27% | -0.53% | $227 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.14% | -0.66% | $214 / yr |
| 🇬🇧 UK ISA | 0% | 2.67% | -0.13% | $267 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.44% | -0.36% | $244 / yr |
| 🇨🇦 TFSA | 0% | 2.67% | -0.13% | $267 / yr |
| 🇨🇦 CA Taxable | 25% | 2.00% | -0.80% | $200 / yr |
| 🇦🇺 Super (pension) | 15% | 2.27% | -0.53% | $227 / yr |
| 🇦🇺 AU Taxable | 30% | 1.87% | -0.93% | $187 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.97% | -0.83% | $197 / yr |
| 🇫🇷 FR Taxable | 30% | 1.87% | -0.93% | $187 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ZTS Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.09/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ZTS Dividend Payment Schedule
ZTS pays quarterly — 4 times per year. Ex-div: 2026-10-30.
📊 ZTS vs Healthcare Benchmarks
How ZTS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ZTS sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ZTS Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-10-09 | 720.144 | — | — | ||
| A-Award | 2026-10-09 | 360.073 | — | — | ||
| A-Award | 2026-10-09 | 277.772 | — | — | ||
| A-Award | 2026-10-09 | 367.788 | — | — | ||
| A-Award | 2026-10-09 | 303.49 | — | — | ||
| A-Award | 2026-10-09 | 52.983 | — | — | ||
| A-Award | 2026-10-09 | 321.495 | — | — | ||
| A-Award | 2026-10-09 | 367.788 | — | — | ||
| M-Exempt | 2026-09-30 | 799 | — | — | ||
| F-InKind | 2026-09-30 | 274 | $69.83 | $19.1K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare ZTS with peers: ZTS vs ARGX · ZTS vs BDX · ZTS vs CI
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where ZTS earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ZTS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Zoetis Inc. (ZTS) is currently trading at $78.23, 47% below its 52-week high. The current dividend yield is 2.67% based on an annual payout of $2.09 per share.
ZTS (Zoetis Inc.) — 2.67% Dividend Yield Analysis
Zoetis Inc. (ZTS) is a healthcare stock currently trading at $78.23 with a dividend yield of 2.67%. It pays an annual dividend of $2.09 per share. The payout ratio of 35% suggests the dividend is well-covered by earnings. Over the past 5 years, ZTS has grown its dividend at a compound annual rate of 20.2%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest ZTS News
LiveHow investors use the ZTS dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.